
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The RNA-binding protein CELF1 targets ATG5 to regulate autophagy and promote drug resistance in acute myeloid leukemia - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="FF20832F89B754F31A832F002667713E.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cddis">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334686/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cell Death &amp; Disease">
<meta name="citation_title" content="The RNA-binding protein CELF1 targets ATG5 to regulate autophagy and promote drug resistance in acute myeloid leukemia">
<meta name="citation_author" content="Xiaoyan Li">
<meta name="citation_author_institution" content="School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China">
<meta name="citation_author" content="Qiyi Qian">
<meta name="citation_author_institution" content="School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China">
<meta name="citation_author" content="Juejiashan Li">
<meta name="citation_author_institution" content="School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China">
<meta name="citation_author" content="Lu Zhang">
<meta name="citation_author_institution" content="School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, China">
<meta name="citation_author" content="Lifang Wang">
<meta name="citation_author_institution" content="School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China">
<meta name="citation_author" content="Dongsheng Huang">
<meta name="citation_author_institution" content="School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China">
<meta name="citation_author_institution" content="Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang China">
<meta name="citation_author" content="Qiuran Xu">
<meta name="citation_author_institution" content="School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China">
<meta name="citation_author_institution" content="Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang China">
<meta name="citation_author" content="Wenhu Chen">
<meta name="citation_author_institution" content="School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="16">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="599">
<meta name="citation_doi" content="10.1038/s41419-025-07926-0">
<meta name="citation_pmid" content="40781108">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334686/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334686/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334686/pdf/41419_2025_Article_7926.pdf">
<meta name="description" content="Acute myeloid leukemia (AML) is a blood cancer characterized by uncontrolled growth of myeloid cells. Overcoming AML treatment resistance, particularly to anthracycline-based drugs like doxorubicin (ADR), poses a challenge. This study investigated ...">
<meta name="og:title" content="The RNA-binding protein CELF1 targets ATG5 to regulate autophagy and promote drug resistance in acute myeloid leukemia">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Acute myeloid leukemia (AML) is a blood cancer characterized by uncontrolled growth of myeloid cells. Overcoming AML treatment resistance, particularly to anthracycline-based drugs like doxorubicin (ADR), poses a challenge. This study investigated ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334686/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12334686">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41419-025-07926-0"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41419_2025_Article_7926.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334686%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12334686/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12334686/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334686/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cddis.gif" alt="Cell Death &amp; Disease logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cell Death &amp; Disease" title="Link to Cell Death &amp; Disease" shape="default" href="http://www.nature.com/cddis/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cell Death Dis</button></div>. 2025 Aug 8;16(1):599. doi: <a href="https://doi.org/10.1038/s41419-025-07926-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41419-025-07926-0</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cell%20Death%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell%20Death%20Dis%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cell%20Death%20Dis%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cell%20Death%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The RNA-binding protein CELF1 targets ATG5 to regulate autophagy and promote drug resistance in acute myeloid leukemia</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Xiaoyan Li</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Xiaoyan Li</span></h3>
<div class="p">
<sup>1</sup>School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaoyan Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qian%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Qiyi Qian</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Qiyi Qian</span></h3>
<div class="p">
<sup>1</sup>School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qian%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qiyi Qian</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Juejiashan Li</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Juejiashan Li</span></h3>
<div class="p">
<sup>1</sup>School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Juejiashan Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Lu Zhang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Lu Zhang</span></h3>
<div class="p">
<sup>2</sup>School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lu Zhang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Lifang Wang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Lifang Wang</span></h3>
<div class="p">
<sup>1</sup>School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lifang Wang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Dongsheng Huang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Dongsheng Huang</span></h3>
<div class="p">
<sup>1</sup>School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China </div>
<div class="p">
<sup>3</sup>Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dongsheng Huang</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Qiuran Xu</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Qiuran Xu</span></h3>
<div class="p">
<sup>1</sup>School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China </div>
<div class="p">
<sup>3</sup>Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qiuran Xu</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Wenhu Chen</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Wenhu Chen</span></h3>
<div class="p">
<sup>1</sup>School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wenhu Chen</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>School of Basic Medical Sciences &amp; Forensic Medicine, Hangzhou Medical College, Hangzhou, China </div>
<div id="Aff2">
<sup>2</sup>School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, China </div>
<div id="Aff3">
<sup>3</sup>Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang China </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Nov 21; Revised 2025 Jun 27; Accepted 2025 Jul 29; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12334686  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40781108/" class="usa-link">40781108</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Acute myeloid leukemia (AML) is a blood cancer characterized by uncontrolled growth of myeloid cells. Overcoming AML treatment resistance, particularly to anthracycline-based drugs like doxorubicin (ADR), poses a challenge. This study investigated the role of CELF1, an RNA-binding protein, in ADR resistance and autophagy regulation in AML. CELF1 expression was elevated in multiple tumor types, including AML. AML cell lines exhibit varying levels of CELF1 expression, with drug-resistant cell lines showing higher CELF1 expression compared to parental cells. CELF1 knockdown reduced drug resistance, promoted cell death, and inhibited autophagy. Mechanistic analysis identified ATG5 as a potential CELF1-regulated target gene, with CELF1 knockdown reducing ATG5 expression and mRNA decay. These findings indicate that targeting CELF1 could overcome ADR resistance in AML by modulating autophagy through ATG5 regulation, highlighting its clinical significance as a therapeutic target for enhancing ADR response in AML.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Cancer, Prognostic markers</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Acute Myeloid Leukemia (AML) is a type of blood cancer characterized by abnormal proliferation and differentiation of myeloid cells, with high mortality rates primarily affecting older adults [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. The overall 5-year survival rate is less than 40% [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. The hallmark features of AML include immature myeloid cell heterogeneity and rapid growth rate, leading to disrupted normal hematopoiesis. Despite the development of novel agents and improved treatment strategies, relapse and drug resistance remain major hurdles towards achieving optimal cure rates for AML patients [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Abnormalities in key genes during the progression of the disease may be crucial drivers of AML development and drug resistance [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Therefore, exploring novel biomarkers and gaining a deeper understanding of their impact on the biological characteristics of AML and the molecular mechanisms of clinical resistance could potentially enhance treatment outcomes and survival rates for AML patients.</p>
<p id="Par3">The occurrence and development of AML are largely influenced by the regulation of RNA-binding proteins (RBP). Research has shown that aberrant expression of RBPs is often associated with enhanced transcriptional and post-transcriptional mechanisms promoting cancer progression [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. CELF1, a member of the CUGBP Elav-like family (CELF) of RNA-binding proteins, was initially identified as an RBP binding to the CUG triplet repeat sequence within muscle atrophy kinase mRNA. It plays a crucial role in the pathogenesis of Myotonic dystrophy (dystrophia myotonica, DM) [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Further studies have revealed that CELF1 binds specifically to certain RNA elements and regulates numerous post-transcriptional processes such as alternative splicing, translational control, and mRNA decay regulation, thereby contributing to the progression of various human diseases, including cancer [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>–<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. However, research on CELF1 in AML has not been reported. Our study found that CELF1 is abnormally highly expressed in AML cells, with a more pronounced expression observed in Adriamycin-resistant (ADR) cells. Further exploration revealed that CELF1 may be involved in the regulation of autophagy in ADR resistance, but the key molecular mechanisms remain to be elucidated.</p>
<p id="Par4">The development of chemotherapy resistance in hematological malignancies poses a significant challenge to clinical treatment, representing one of the major obstacles in tumor therapy [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Research has demonstrated that autophagy plays a crucial role in tumorigenesis and progression [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Specifically, autophagy can eliminate mutated cells, damaged cellular organelles, and genomic instability during early stages of tumor formation, thereby inhibiting tumor initiation [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. In established tumors, autophagy is enhanced as a response to nutrient deprivation, energy insufficiency, hypoxic stress, and chemotherapy-induced damage, allowing cancer cells to continue growth and dissemination without destruction, ultimately leading to the induction of acquired resistance [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>–<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. In certain hematological malignancies, autophagy has been found to be a key mechanism that enables tumor cells to evade immune surveillance and killing [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>–<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. Moreover, after exposure to chemotherapeutic agents, autophagy can be activated in these cancer cells, resulting in the development of drug resistance [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>–<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>].</p>
<p id="Par5">This study discovered that CELF1 specifically binds to the mRNA of ATG5, a critical gene involved in autophagy regulation, and promotes its expression in ADR-resistant acute myeloid leukemia (AML) cells. This activation of protective autophagy enhances the AML cells’ resistance to ADR treatment. Furthermore, we established an in vivo model system to validate CELF1’s regulatory role on ATG5-mediated autophagy as a tumor-suppressive mechanism. Therefore, targeting CELF1 specifically or inhibiting ATG5-mediated autophagy has significant implications for further translational research and clinical application in AML treatment.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec3"><h3 class="pmc_sec_title">CELF1 is a potential target for ADR resistance in AML cells</h3>
<p id="Par6">Firstly, we conducted a pan-cancer analysis of CELF1 expression using TCGA data, revealing significantly elevated levels of CELF1 across various tumors, with the most notable difference observed in AML (Fig. <a href="#Fig1" class="usa-link">1A, B</a>). Clinical baseline data indicates a significant correlation between high CELF1 expression and lower classifications within the FAB system (M0&amp;M1&amp;M2), while no significant correlations were found with Bone Marrow Blasts proportion, Age, Cytogenetic risk, and FLT3 mutation (Table <a href="#Tab1" class="usa-link">1</a>). Then, We selected five commonly used AML cell lines (HL-60, MOLM-13, U937, THP-1, and KG-1) to investigate CELF1 expression levels using RT-qPCR and Western Blot. The results indicate that the levels of CELF1 mRNA and protein expression in AML cell lines are significantly higher than those in HS-5. Furthermore, there are variations in CELF1 expression levels among the different cell lines, with KG-1 exhibiting the highest expression and HL-60 the lowest (Fig. <a href="#Fig1" class="usa-link">1C, D</a>). To validate the relationship between CELF1 expression and ADR resistance, we conducted CCK-8 assays on KG-1 and HL-60 cells. Compared to HL-60 cells, KG-1 cells demonstrated significant resistance to ADR treatment (Fig. <a href="#Fig1" class="usa-link">1E</a>). Notably, the IC<sub>50</sub> values of ADR in KG-1 cells were substantially higher than those observed in HL-60 cells (228.6 ± 8.3 nM vs. 84.21 ± 3.03 nM) (Fig. <a href="#Fig1" class="usa-link">1F</a>). We established two ADR-resistant cell lines, KG-1/ADR (2558 ± 86 nM) and HL-60/ADR (1328 ± 41 nM), which exhibited increased IC<sub>50</sub> values compared to their parental cells. Specifically, the IC<sub>50</sub> values of KG-1/ADR and HL-60/ADR cells increased by ~10-fold (Fig. <a href="#Fig1" class="usa-link">1G, H</a>). RT-qPCR and Western Blot analysis revealed that CELF1 expression was significantly upregulated in both resistant cell lines (Fig. <a href="#Fig1" class="usa-link">1I, J</a>). This finding suggests a potential clinical relevance for targeting CELF1 to overcome ADR resistance in AML.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. CELF1 is overexpressed in in AML drug-resistant cell lines.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334686_41419_2025_7926_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8411/12334686/ea68500dcecd/41419_2025_7926_Fig1_HTML.jpg" loading="lazy" id="d33e395" height="734" width="790" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> Pan-cancer expression of CELF1 between tumor tissues and normal tissues from TCGA. <strong>C</strong>, <strong>D</strong> RT-qPCR and Western Blot evaluate CELF1 expression across diverse AML cell lines. <strong>E</strong>, <strong>F</strong> The IC<sub>50</sub> values and inhibitory curve in KG-1 and HL-60 cells with ADR tested. <strong>G</strong>, <strong>H</strong> The IC<sub>50</sub> values and inhibitory curve in KG-1/ADR and HL-60/ADR cells with ADR tested. <strong>I</strong>, <strong>J</strong> RT-qPCR and Western Blot analysis of CELF1 expression in AML drug-resistant cells compared to parental cells.</p></figcaption></figure><section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Correlations between CELF1 expression and clinicopathologic features of AML patients.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">Characteristics</th>
<th colspan="1" rowspan="1">Low expression of CELF1</th>
<th colspan="1" rowspan="1">High expression of CELF1</th>
<th colspan="1" rowspan="1">
<em>P</em> value</th>
</tr></thead>
<tbody>
<tr>
<td colspan="1" rowspan="1"><em>n</em></td>
<td colspan="1" rowspan="1">75</td>
<td colspan="1" rowspan="1">75</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gender, <em>n</em> (%)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">0.412</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Female</td>
<td colspan="1" rowspan="1">36 (24%)</td>
<td colspan="1" rowspan="1">31 (20.7%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Male</td>
<td colspan="1" rowspan="1">39 (26%)</td>
<td colspan="1" rowspan="1">44 (29.3%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Race, <em>n</em> (%)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">0.979</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Asian&amp;Black or African American</td>
<td colspan="1" rowspan="1">7 (4.7%)</td>
<td colspan="1" rowspan="1">7 (4.7%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> White</td>
<td colspan="1" rowspan="1">68 (45.6%)</td>
<td colspan="1" rowspan="1">67 (45%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">FAB classifications, <em>n</em> (%)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">0.022*</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> M0&amp;M1&amp;M2</td>
<td colspan="1" rowspan="1">36 (24.2%)</td>
<td colspan="1" rowspan="1">52 (34.9%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> M3</td>
<td colspan="1" rowspan="1">9 (6%)</td>
<td colspan="1" rowspan="1">5 (3.4%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> M4&amp;M5&amp;M6&amp;M7</td>
<td colspan="1" rowspan="1">30 (20.1%)</td>
<td colspan="1" rowspan="1">17 (11.4%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">BM blasts(%), <em>n</em> (%)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">0.867</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≤20</td>
<td colspan="1" rowspan="1">29 (19.3%)</td>
<td colspan="1" rowspan="1">30 (20%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &gt;20</td>
<td colspan="1" rowspan="1">46 (30.7%)</td>
<td colspan="1" rowspan="1">45 (30%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Age, <em>n</em> (%)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">0.408</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≤60</td>
<td colspan="1" rowspan="1">46 (30.7%)</td>
<td colspan="1" rowspan="1">41 (27.3%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &gt;60</td>
<td colspan="1" rowspan="1">29 (19.3%)</td>
<td colspan="1" rowspan="1">34 (22.7%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">WBC count(×10^9/L), <em>n</em> (%)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">0.933</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> ≤20</td>
<td colspan="1" rowspan="1">38 (25.5%)</td>
<td colspan="1" rowspan="1">38 (25.5%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &gt; 20</td>
<td colspan="1" rowspan="1">36 (24.2%)</td>
<td colspan="1" rowspan="1">37 (24.8%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cytogenetic risk, <em>n</em> (%)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">0.487</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Favorable</td>
<td colspan="1" rowspan="1">15 (10.1%)</td>
<td colspan="1" rowspan="1">15 (10.1%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Intermediate/normal</td>
<td colspan="1" rowspan="1">44 (29.7%)</td>
<td colspan="1" rowspan="1">38 (25.7%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Poor</td>
<td colspan="1" rowspan="1">15 (10.1%)</td>
<td colspan="1" rowspan="1">21 (14.2%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">FLT3 mutation, <em>n</em> (%)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">0.432</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Negative</td>
<td colspan="1" rowspan="1">52 (35.6%)</td>
<td colspan="1" rowspan="1">49 (33.6%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Positive</td>
<td colspan="1" rowspan="1">20 (13.7%)</td>
<td colspan="1" rowspan="1">25 (17.1%)</td>
<td colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p9">
<p>Clinical data were derived from The Cancer Genome Atlas (TCGA) AML cohort.</p>
<p><em>AML</em> acute myelogenous leukemia, <em>FAB</em> French-American-British classification, <em>WBC</em> White Blood Cell.</p>
</div></div></section></section><section id="Sec4"><h3 class="pmc_sec_title">CELF1 knockdown promotes drug sensitivity and reduces autophagy in AML cells</h3>
<p id="Par7">In the treatment of acute myeloid leukemia (AML), the development of drug resistance remains a major cause of chemotherapy failure and disease relapse. Recent studies suggest that autophagy, a critical regulatory mechanism of cellular metabolic homeostasis, plays a pivotal role in AML drug resistance. Therefore, We performed Western blot to assess the expression of three key autophagy markers (p62, Beclin-1, LC3-II/LC3-I) to evaluate changes in autophagy levels in drug-resistant cells and their parental counterparts. The results revealed increased LC3-II/LC3-I ratios, decreased p62 protein levels, and elevated Beclin1 protein levels in HL-60/ADR and KG-1/ADR cells compared to HL-60 and KG-1 cells, indicating significantly enhanced autophagic activity in the resistant cells (Supplementary Fig. <a href="#MOESM2" class="usa-link">S1A</a>). Treatment with the autophagy inhibitor Bafilomycin A1 (BafA1) markedly suppressed autophagic activation in HL-60/ADR and KG-1/ADR cells (Supplementary Fig. <a href="#MOESM2" class="usa-link">S1B</a>). Tandem GFP-mRFP-LC3 fluorescence analysis showed that BafA1 treatment decreased the number of yellow and red puncta in HL-60/ADR and KG-1/ADR cells, confirming its role in reversing autophagy activation in drug-resistant cells (Supplementary Fig. <a href="#MOESM2" class="usa-link">S1C</a>). Furthermore, CCK-8 assays demonstrated that BafA1 reduced the IC<sub>50</sub> values of ADR in both resistant cell lines (Supplementary Fig. <a href="#MOESM2" class="usa-link">S1D</a>).</p>
<p id="Par8">To validate the role of CELF1 in AML drug resistance, we used siRNA to knockdown CELF1 expression in KG-1/ADR and HL-60/ADR cells, with the silencing efficiency demonstrated in Supplementary Fig. <a href="#MOESM2" class="usa-link">S2A, B</a>. CCK-8 assay results indicated that downregulation of CELF1 significantly diminished the drug-resistant phenotype (Fig. <a href="#Fig2" class="usa-link">2A, B</a>). Furthermore, flow cytometry results showed that CELF1 knockdown significantly increased ADR-induced cell apoptosis (Fig. <a href="#Fig2" class="usa-link">2C, D</a>). Results of Western blot revealed a significant upregulation of p62 expression and a marked decrease in the ratio of LC3-II/LC3-I and Beclin-1 expression after CELF1 knockdown (Fig. <a href="#Fig2" class="usa-link">2E</a>), indicating that CELF1 knockdown can inhibit autophagy levels. Transmission electron microscopy images confirmed these findings, showing a significant reduction in the number of autophagosomes in CELF1 knockdown KG-1/ADR and HL-60/ADR cells compared to the control group (Fig. <a href="#Fig2" class="usa-link">2F, G</a>). Additionally, we conducted tandem mRFP-GFP-LC3 fluorescence analysis. The results indicated that knockdown of CELF1 resulted in a reduction in the number of yellow and red puncta in HL-60/ADR and KG-1/ADR cells, effectively block autophagic flux (Fig. <a href="#Fig2" class="usa-link">2H, I</a>). The above results indicate that CELF1 knockdown promotes AML cell apoptosis and inhibits autophagy.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. CELF1 knockdown promotes cell apoptosis and inhibits autophagy.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334686_41419_2025_7926_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8411/12334686/ebb84c33a6c1/41419_2025_7926_Fig2_HTML.jpg" loading="lazy" id="d33e753" height="801" width="790" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> CCK8 assess IC<sub>50</sub> values and inhibition curves after CELF1 knockdown in KG-1/ADR and HL-60/ADR cells. <strong>C</strong>, <strong>D</strong> Flow cytometry analysis of apoptosis in cells following CELF1 knockdown. <strong>E</strong> Western blot analysis of autophagy markers in cells after CELF1 knockdown. <strong>F</strong>, <strong>G</strong> Autophagic organelles visualized by transmission electron microscopy in cells after CELF1 knockdown. <strong>H</strong>, <strong>I</strong> Tandem mRFP-GFP-LC3 fluorescence assay performed in CELF1 knockdown cells to monitor autophagic flux.</p></figcaption></figure></section><section id="Sec5"><h3 class="pmc_sec_title">CELF1 enhances AML cell sensitivity to ADR through inhibition of autophagy</h3>
<p id="Par9">Previous studies have indicated that autophagy is a potential mechanism of resistance to various cytotoxic drugs in a range of cancers, including hematologic malignancies. Therefore, we further investigated whether CELF1 promotes ADR resistance in AML cells by inhibiting cellular autophagy. We conducted rescue experiments by treating KG-1/ADR and HL-60/ADR cells with the autophagy inducer rapamycin (Rapa). CCK-8 assay revealed that cells treated with Rapa exhibited higher ADR IC<sub>50</sub> values compared to the si-NC group, indicating increased ADR resistance. This suggests that enhancing autophagy in AML cells indeed contributes to ADR resistance. Our previous findings demonstrated that depletion of CELF1 significantly reduced ADR resistance, and adding Rapa on this basis partially restored ADR resistance (Fig. <a href="#Fig3" class="usa-link">3A, B</a>). Similarly, flow cytometry results showed that Rapa alone could inhibit cell apoptosis, while adding Rapa to CELF1 knockdown cells partially suppressed the apoptosis induced by CELF1 downregulation (Fig. <a href="#Fig3" class="usa-link">3C, D</a>). This suggests that CELF1 likely promotes AML cell resistance to ADR through regulating cellular autophagy. Subsequently, we used Western blot analysis to examine the expression of autophagy markers. The results showed that compared to the si-NC group, p62 expression was significantly reduced in the Rapa group, while the ratio of LC3-II/LC3-I and Beclin-1 expression markedly increased, indicating that Rapa significantly enhanced cellular autophagy levels. In CELF1-knocked down cells treated with Rapa, p62 expression increased, and the ratio of LC3-II/LC3-I and Beclin-1 expression decreased significantly compared to the group with only CELF1 knockdown (Fig. <a href="#Fig3" class="usa-link">3E</a>). Additionally, transmission electron microscopy results demonstrated an increase in autophagosome formation with Rapa treatment, with more autophagosomes observed in CELF1 knockdown cells treated with Rapa compared to the group with only CELF1 downregulation(Fig. <a href="#Fig3" class="usa-link">3F, G</a>). The results of the tandem mRFP-GFP-LC3 fluorescence assay showed that treatment with Rapa alone significantly increased autophagic flux in HL-60/ADR and KG-1/ADR cells. However, knockdown of CELF1 expression in these cells partially reversed the Rapa-induced enhancement of autophagic flux(Fig. <a href="#Fig3" class="usa-link">3H, I</a>). These suggest that the addition of Rapa can restore cellular autophagy and ADR drug sensitivity in CELF1 knockdown cells.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3. ADR resistance and autophagy induction following CELF1 knockdown and Rapa treatment.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334686_41419_2025_7926_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8411/12334686/9c4590f8d88f/41419_2025_7926_Fig3_HTML.jpg" loading="lazy" id="d33e813" height="940" width="790" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> CCK8 assess IC<sub>50</sub> values and inhibition curves after CELF1 knockdown and Rapa treatment in AML cells. <strong>C</strong>, <strong>D</strong> Flow cytometry analysis of apoptosis in cells following CELF1 knockdown and Rapa treatment. <strong>E</strong> Western blot analysis of autophagy markers in cells after CELF1 knockdown and Rapa treatment. <strong>F</strong>, <strong>G</strong> Autophagic organelles visualized by transmission electron microscopy in cells after CELF1 knockdown and Rapa treatment. <strong>H</strong>, <strong>I</strong> Tandem mRFP-GFP-LC3 fluorescence assay performed in cells after CELF1 knockdown and Rapa treatment to monitor autophagic flux.</p></figcaption></figure></section><section id="Sec6"><h3 class="pmc_sec_title">ATG5 is a potential downstream target of CELF1</h3>
<p id="Par10">In order to identify downstream target genes regulated by CELF1 in AML cells, we performed RNA-seq high-throughput sequencing on KG-1/ADR cells before and after CELF1 knockdown. The transcriptome analysis encompassed 33,094 genes, of which 987 showed statistically significant changes in expression following CELF1 knockdown, with 490 genes upregulated and 497 genes downregulated (|log2FC|≥ 1, <em>P</em> &lt; 0.05). The heatmap displayed illustrates the top 100 upregulated and downregulated genes (Fig. <a href="#Fig4" class="usa-link">4A</a>). In the GO enrichment analysis, several GO terms related to DNA replication and cell cycle processes were enriched, including DNA replication initiation, DNA strand elongation, double-strand break repair, and cell cycle phase transition, which were the most enriched biological processes. This finding was consistent with our cell proliferation data (Fig. <a href="#Fig4" class="usa-link">4B</a>). In the KEGG pathway enrichment analysis (Fig. <a href="#Fig4" class="usa-link">4C</a>), the most significant pathways, listed in ascending order of <em>p</em>-value, included DNA replication, Cell cycle, Pathways in cancer, MAPK signaling pathway, and PI3K-Akt signaling pathway. To identify CELF1 target genes, we applied more stringent criteria to the differentially expressed genes from sequencing, using a <em>P</em> &lt; 0.01 and a fold change of 3, presented in a volcano plot (Fig. <a href="#Fig4" class="usa-link">4D</a>). After excluding non-coding genes from the 153 downregulated genes, we obtained 146 protein-coding genes. Intersection analysis with the Human Autophagy Database(HADb) revealed ATG5 and CDKN1A as potential target genes of CELF1 (Fig. <a href="#Fig4" class="usa-link">4E</a>). Furthermore, analysis of the correlation between CELF1 and ATG5/CDKN1A expression in the TCGA database showed a significant positive correlation between CELF1 and ATG5 (R = 0.481, <em>P</em> &lt; 0.001), while no significant correlation was found between CELF1 and CDKN1A (R = 0.083, <em>P</em> = 0.311) (Fig. <a href="#Fig4" class="usa-link">4F</a>). Subsequent RT-qPCR and Western blot analyses demonstrated that knocking down CELF1 significantly reduced ATG5 expression, while the expression of CDKN1A did not show significant changes (Fig. <a href="#Fig4" class="usa-link">4G, H</a>), indicating that ATG5 is an important target gene regulated by CELF1 in controlling cellular autophagy.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4. RNA-seq analysis of potential downstream targets following CELF1 depletion.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334686_41419_2025_7926_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8411/12334686/dfb13506d0bd/41419_2025_7926_Fig4_HTML.jpg" loading="lazy" id="d33e888" height="585" width="790" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> The heat map illustrates DEGs following CELF1 depletion. <strong>B</strong> The top 20 enriched GO terms among DEGs. <strong>C</strong> The top 20 enriched KEGG pathways among DEGs. <strong>D</strong> Volcano plot showing 240 DEGs following CELF1 knockdown. <strong>E</strong> Venn diagram displays the common genes between the downregulated coding genes and the HADb. <strong>F</strong> Spearman’s correlation analysis of ATG5, CDKN1A with CELF1 expression in the AML profiles of TCGA dataset. <strong>G</strong>, <strong>H</strong> RT-qPCR and Western blot analysis the expression of ATG5 and CDKN1A following CELF1 depletion.</p></figcaption></figure></section><section id="Sec7"><h3 class="pmc_sec_title">CELF1 interacts with ATG5 mRNA and maintains its stability</h3>
<p id="Par11">To further explore the potential molecular mechanism of CELF1 in regulating ATG5 expression, we conducted RIP assays to validate the targeting of ATG5 mRNA by CELF1 protein. The combined results of RIP and RT-qPCR showed that the CELF1-specific antibody effectively co-precipitated ATG5 mRNA compared to the negative IgG control (Fig. <a href="#Fig5" class="usa-link">5A</a>). Additionally, using biotin-labeled ATG5 mRNA sequences and their reverse sequences in RNA pull-down experiments, Western blot results demonstrated specific interaction between ATG5 mRNA and CELF1 protein, confirming their relationship (Fig. <a href="#Fig5" class="usa-link">5B</a>). In mRNA decay experiments, after actinomycin D treatment, the abundance of ATG5 mRNA in the CELF1 knockdown group decreased significantly over time compared to the control group, indicating that CELF1 specifically binds to ATG5 mRNA in AML cells and increases its half-life (Fig. <a href="#Fig5" class="usa-link">5C, D</a>).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5. CELF1 binds to ATG5 mRNA and preserves its stability.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334686_41419_2025_7926_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8411/12334686/823f43d80752/41419_2025_7926_Fig5_HTML.jpg" loading="lazy" id="d33e937" height="638" width="790" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> RIP-qPCR analysis confirmed CELF1 binding to ATG5 mRNA, normalized against the input group with IgG as the negative control. <strong>B</strong> The RNA pull-down assay and western blot analysis confirmed the direct binding of biotinylated ATG5 to CELF1 proteins. <strong>C</strong>, <strong>D</strong> CELF1 depletion was studied for its effect on ATG5 mRNA stability in AML cells by actinomycin D-chase experiments. <strong>E</strong>, <strong>F</strong> Schematic representation of CELF1 binding motifs on ATG5 and the fragmented ATG5 mRNA biotinylated transcripts. <strong>G</strong> Representative CELF1 immunoblots of the material pulled down by the different biotinylated fragments of the ATG5 mRNA. <strong>H</strong> Binding sites of CELF1 on ATG5 and mutant sequences. <strong>I</strong> Dual-luciferase reporter assay demonstrating CELF1-mediated regulation of ATG5 mRNA abundance.</p></figcaption></figure><p id="Par12">Previous studies have shown that CELF1, as a crucial RNA-binding protein, can specifically recognize CUG, UG, and UA repeat sequences (such as CUGCUG, UGUGUG, UAUAUA, etc.) [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>–<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Through sequence alignment, we identified two UGUGUG sites in the CDS region and one CUGCUG site in the 3’UTR region of ATG5 mRNA (Fig. <a href="#Fig5" class="usa-link">5E</a>). Subsequently, we fragmented ATG5 mRNA into smaller transcripts to determine specific binding sites for CELF1. By constructing biotin-labeled full-length ATG5 transcript (FL) and three region fragments (F1, F2, and F3), we conducted RNA pull-down analysis (Fig. <a href="#Fig5" class="usa-link">5F</a>). The results showed the strongest binding affinity of CELF1 to the F1 region, weaker binding to the F2 region, and no observed binding to F3 (Fig. <a href="#Fig5" class="usa-link">5G</a>). These findings clearly demonstrate that CELF1 can specifically bind to ATG5 mRNA, with its highest affinity spanning the CDS region.</p>
<p id="Par13">To elucidate whether CELF1 regulates the stability of ATG5 mRNA by specifically recognizing the UGUGUG motif and to demonstrate the efficiency and effect of the binding site, we designed mutated sequences for the binding site and created a model diagram (Fig. <a href="#Fig5" class="usa-link">5H</a>). Subsequently, we constructed luciferase reporter vectors containing either the wild-type ATG5 mRNA (with the UGUGUG motif) or the mutated sequence (ACACAC) and transfected them into 293T cells. By co-transfecting with the OE-CELF1 plasmid and measuring changes in luciferase activity, we found that CELF1 overexpression significantly increased luciferase activity in the wild-type group, indicating an enhancement in mRNA stability or translation efficiency, while this effect was completely abolished in the MUT1 (<sub>250</sub>UGUGUG<sub>255</sub>) (Fig. <a href="#Fig5" class="usa-link">5H</a>). These results provide direct evidence that CELF1 regulates the stability of ATG5 mRNA by binding to its UGUGUG motif, offering molecular-level insights into their functional interaction.</p></section><section id="Sec8"><h3 class="pmc_sec_title">CELF1 regulates autophagy in AML cells via ATG5 to promote ADR resistance</h3>
<p id="Par14">To confirm whether CELF1 influences cellular autophagy and ADR resistance by targeting ATG5, we conducted rescue experiments, with the overexpression efficiency of ATG5 demonstrated in Supplementary Fig. <a href="#MOESM2" class="usa-link">S2C, D</a>. The results from the CCK-8 assay showed that Compared to the si-NC group, the IC<sub>50</sub> of the si-CELF1 group was significantly reduced. Furthermore, following the knockdown of CELF1, overexpression of ATG5 resulted in a significant increase in the IC<sub>50</sub> value in the si-CELF1 + OE-ATG5 group compared to the si-CELF1 group, indicating that overexpression of ATG5 partially reversed the increased sensitivity to ADR in CELF1-knocked down KG-1/ADR and HL-60/ADR cells (Fig. <a href="#Fig6" class="usa-link">6A, B</a>). Similarly, flow cytometry results demonstrated that in KG-1/ADR and HL-60/ADR cells with CELF1 knockdown alone, apoptosis was significantly higher compared to the control group, while in the rescue group with ATG5 overexpression on the basis of CELF1 knockdown, this phenomenon was significantly reversed (Fig. <a href="#Fig6" class="usa-link">6C, D</a>). This suggests that CELF1 likely mediates ADR resistance through targeting ATG5. Furthermore, we used Western blot analysis to examine autophagy-related proteins. The results showed that overexpression of ATG5 reversed the decreased ratio of LC3-II/LC3-I and Beclin-1 levels, and reduced the upregulation of p62 in CELF1-knocked down KG-1/ADR and HL-60/ADR cells (Fig. <a href="#Fig6" class="usa-link">6E</a>). Additionally, transmission electron microscopy results indicated that knocking down CELF1 reduced the formation of autophagosomes in cells, while a slight increase in the number of autophagosomes was observed in cells overexpressing ATG5 on the basis of CELF1 knockdown (Fig. <a href="#Fig6" class="usa-link">6F, G</a>). The tandem mRFP-GFP-LC3 reporter assay demonstrated that CELF1 knockdown significantly suppressed cellular autophagic flux. Notably, this suppression was partially reversed by ATG5 overexpression in CELF1- depleted cells (Fig. <a href="#Fig6" class="usa-link">6H, I</a>). This suggests that CELF1 can regulate cellular autophagy through ATG5.</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6. CELF1 modulates AML cell autophagy via ATG5 to combat ADR resistance.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334686_41419_2025_7926_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8411/12334686/e0145c4743b3/41419_2025_7926_Fig6_HTML.jpg" loading="lazy" id="d33e1031" height="960" width="790" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> CCK8 assess IC<sub>50</sub> values and inhibition curves after CELF1 knockdown and ATG5 upregulation in AML cells. <strong>C</strong>, <strong>D</strong> Flow cytometry analysis of apoptosis in cells following CELF1 knockdown and ATG5 upregulation. <strong>E</strong> Western blot analysis of autophagy markers in cells after CELF1 knockdown and ATG5 upregulation. <strong>F</strong>, <strong>G</strong> Autophagic organelles visualized by transmission electron microscopy in cells after CELF1 knockdown and ATG5 upregulation. <strong>H</strong>, <strong>I</strong> Tandem mRFP-GFP-LC3 fluorescence assay performed in cells after CELF1 knockdown and ATG5 upregulated to monitor autophagic flux.</p></figcaption></figure><p id="Par15">In addition, we explored the effect of Rapa on the mTOR pathway in drug-resistant cells to determine whether the resistance and the effect of rapamycin arise from different pathways. Rapa treatment significantly reduced phosphorylated mTOR (p-mTOR) levels in drug-resistant cells while markedly inducing autophagy (Supplementary Fig. <a href="#MOESM2" class="usa-link">S3A</a>). These findings indicate that Rapa effectively inhibits mTOR activity in drug-resistant cells, thereby relieving its suppression on autophagy. Further investigation demonstrated that CELF1 knockdown did not alter the expression of mTOR pathway-related proteins (Supplementary Fig. <a href="#MOESM2" class="usa-link">S3B</a>), suggesting that the drug resistance mechanism regulates autophagy through the CELF1-ATG5 axis independently of the mTOR pathway. This evidence further supports the critical regulatory role of the CELF1-ATG5 axis in AML drug resistance.</p></section><section id="Sec9"><h3 class="pmc_sec_title">CELF1 knockdown combined with ADR treatment improves AML xenograft model survival</h3>
<p id="Par16">To further elucidate the role of CELF1 in AML cell resistance in vivo, we established a disseminated AML mouse model using HL-60/ADR cells stably expressing luciferase. Three days after cell injection, ADR treatment was administered, and bioluminescence imaging was performed on days 7, 14, and 28 to track the fate of the target cells. The Blank group received no drug treatment, and the In Vivo Imaging system revealed rapid growth of AML cells. The remaining three groups underwent ADR treatment under the same conditions. In vivo fluorescence imaging showed that stable knockdown of CELF1 significantly reduced fluorescence intensity compared to the NC group, indicating that CELF1 knockdown effectively increased tumor cell killing and sensitivity to ADR. Overexpression of ATG5 on the basis of CELF1 knockdown increased fluorescence intensity, suggesting that the rescue effect of ATG5 partially reversed cell ADR resistance (Fig. <a href="#Fig7" class="usa-link">7A, B</a>). Furthermore, bone marrow cells from some mice after 28 days were subjected to flow cytometry analysis. The results showed that the Blank group had a high positivity rate of CD45<sup>+</sup> cells at 74%, while the NC group had 46.6% CD45<sup>+</sup> cells. In the CELF1 knockdown group, the CD45<sup>+</sup> cell proportion was only 7.85%, significantly lower than the NC group, and in the ATG5 rescue group, the CD45<sup>+</sup> cell proportion recovered to 24.6% (Fig. <a href="#Fig7" class="usa-link">7C, D</a>). Histological analysis of the spleen, lung, liver, and kidney tissue revealed differential levels of infiltration and tissue damage among the groups. The Blank and NC groups displayed severe tissue infiltration and structural damage, while the CELF1 knockdown group exhibited significantly reduced infiltration and preservation of tissue architecture. In contrast, the ATG5 rescue partially reversed these protective effects, as evidenced by increased infiltration and damage in comparison to the CELF1 knockdown group (Fig. <a href="#Fig7" class="usa-link">7E</a>). Additionally, all ADR treatment groups showed extended survival, with the CELF1 knockdown combined treatment group exhibiting the best survival, while ATG5 rescue weakened some of the treatment effects(Fig. <a href="#Fig7" class="usa-link">7F</a>). It is evident that knockdown CELF1 expression effectively enhances the therapeutic effect of ADR on AML xenografts, and this effect is mediated through the regulation of ATG5 expression.</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7. CELF1 depletion combined with ADR treatment reduced leukemia progression in an AML mouse model.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334686_41419_2025_7926_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8411/12334686/fcf1b20a7a9a/41419_2025_7926_Fig7_HTML.jpg" loading="lazy" id="d33e1093" height="794" width="790" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> Comparison of the evolution of bioluminescence emission in mice treated with ADR in combination with each group or the untreated group after injection of HL-60/ADR Luci cells, measured by the IVIS Spectrum. <strong>C</strong>, <strong>D</strong> CD45<sup>+</sup> cell proportion in mouse bone marrow assessed by flow cytometry in each group. <strong>E</strong> H&amp;E staining shows that CELF1 knockdown reduces leukemic infiltration and preserves tissue structure in the spleen, lung, liver and kidney, while ATG5 overexpression partially reverses this effect. <strong>F</strong> Kaplan–Meier survival curves of the four different treatment groups.</p></figcaption></figure></section></section><section id="Sec10"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par17">Acute Myeloid Leukemia (AML), a severe malignant hematologic tumor, originates from hematopoietic stem cell progenitors [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Among the eight subtypes of AML (M0-M7), only Acute Promyelocytic Leukemia (APL, M3 subtype) can achieve clinical remission rates of over 95% with the use of cytarabine (Ara-C) or all-trans retinoic acid (ATRA) [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. However, other types of AML, while controllable with standard chemotherapy, lead to relapse or drug resistance in around 40% of young patients and the majority of elderly patients [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. The issue of chemoresistance in AML poses a critical challenge in clinical treatment. Numerous studies suggest that RNA-binding proteins (RBPs) play crucial regulatory roles in cells, participating in processes such as gene transcription, splicing, and translation. Aberrant expression of RBPs in tumor cells can alter cellular responses to chemotherapy [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. For instance, abnormal RBP expression can affect the expression or regulation of drug target genes, leading to reduced sensitivity of tumor cells to drugs [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. It may also disrupt normal cellular signaling pathways, promoting cell proliferation or inhibiting apoptosis, thereby enhancing drug resistance [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Therefore, there is an urgent need to broaden our understanding of the relationship between RBPs and AML drug resistance, identify new therapeutic targets for AML clinical resistance, and provide a new theoretical basis for treating relapsed AML.</p>
<p id="Par18">CELF1, also known as CUG-repeat binding protein 1 (CUGBP1), is a novel RNA-binding protein containing three RNA recognition motifs (RRMs) that bind to specific mRNAs and determine their fate [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Studies have shown that CELF1 is primarily found in skeletal muscle, heart, and brain, initially discovered to be involved in the selective translation of muscle atrophy kinase in myotonic dystrophy [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>, <a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Additionally, CELF1 plays important roles in the occurrence and development of various tumors. For example, CELF1 is overexpressed in gastric and lung cancers, and knocking down CELF1 significantly inhibits tumor cell proliferation [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. In gliomas, CELF1 is upregulated and promotes cell proliferation by inhibiting CDKN1B [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Furthermore, CELF1 enhances cell migration, invasion, and chemoresistance in colorectal cancer by targeting ETS2 [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. In this study, analysis of TCGA data revealed significantly higher expression of CELF1 in AML patients compared to normal individuals, suggesting a potential important role for CELF1 in AML progression. To further investigate the relationship between CELF1 expression levels in AML cells and ADR resistance, we established two AML cell lines with acquired resistance, analyzed the differential expression of CELF1 between these cells and their parental cell lines, and found significantly elevated expression of CELF1 in the drug-resistant AML cells. Using CCK-8 assays and siRNA knockdown techniques, we identified CELF1 as a key molecule involved in acquired AML drug resistance. Additionally, we found that knocking down CELF1 affects cellular autophagy levels, which is a critical factor in tumor drug resistance. Therefore, in-depth exploration of CELF1’s regulation of autophagy-mediated AML drug resistance holds significant clinical significance.</p>
<p id="Par19">Cell autophagy is a fundamental physiological process through which cells self-digest damaged or excessive cellular components and structures to maintain intracellular homeostasis, energy balance, and promote cell renewal and remodeling [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Under normal conditions, autophagy plays a crucial role in cell health and longevity. However, in certain abnormal states such as disease or aging, autophagy may become dysregulated, leading to cellular abnormalities [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Previous studies have shown that cellular autophagy can be a survival mechanism triggered by stress conditions like cancer treatment, often contributing to chemotherapy resistance and long-term dormancy of tumor cells, ultimately leading to advanced clinical symptoms of relapse and metastasis [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. For example, docetaxel treatment of triple-negative breast cancer induces autophagy, inactivating the NF-κB signaling pathway, reducing apoptosis rates, and increasing resistance to Epirubicin [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. Autophagy is involved in cadmium resistance in lung epithelial fibroblasts by inducing multidrug resistance protein 1 (MRP1) and balancing endoplasmic reticulum stress [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Additionally, Docetaxel promotes the expression of high mobility group box 1 (HMGB1), enhancing the formation of the autophagy core complex Beclin-1-PI3K-III through the MEK/ERK1/2 pathway, leading to resistance to Docetaxel [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. Currently, several chemotherapy drugs used in AML treatment, such as ADR and cytarabine, can induce autophagy as a survival mechanism to resist cytotoxic stress and counteract the therapeutic effects of these drugs [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. Therefore, identifying the role and potential mechanisms of CELF1 in autophagy regulation may be an effective strategy to enhance efficacy and overcome resistance in AML treatment.</p>
<p id="Par20">To uncover the potential mechanisms by which CELF1 drives acquired drug resistance in AML cells, we conducted RNA-seq high-throughput sequencing analysis of KG-1/ADR cells before and after CELF1 knockdown, revealing significant changes in 987 genes upon CELF1 knockdown. Many of these genes were enriched in Gene Ontology terms related to DNA replication and the cell cycle. In the KEGG pathway enrichment analysis, pathways such as DNA replication, the cell cycle, pathways in cancer, the MAPK signaling pathway, and the PI3K-Akt signaling pathway were enriched. This suggests that CELF1 likely promotes AML cell resistance by regulating downstream target genes involved in these pathways. Subsequently, we identified two downstream target genes of CELF1 involved in regulating autophagy, ATG5 and CDKN1A, through analysis with the Human Autophagy Database. Expression correlation analysis revealed a strong positive correlation between CELF1 and ATG5, while no significant correlation was found between CELF1 and CDKN1A. Our RT-qPCR and Western blot results showed significant downregulation of ATG5 and no significant change in CDKN1A expression upon CELF1 knockdown. Rescue experiments both in vitro and in vivo further confirmed that CELF1 enhances AML cell tolerance to ADR, with CELF1 increasing cell resistance through regulation of ATG5 expression. Autophagy is a tightly regulated process, with key participants being autophagy-related (ATG) proteins. Among the identified 41 ATG genes, ATG5 is essential for autophagosome formation and positively influences autophagic activity [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. m<sup>6</sup>A-modified USP13 induces autophagy and imatinib resistance in gastrointestinal stromal tumor cells by regulating ATG5 stability [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. miR-137 promotes sensitivity of pancreatic cancer cells to ADR by inhibiting ATG5-mediated autophagy [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. Additionally, exosomal LOC85009 regulates cell autophagy to inhibit resistance to docetaxel through the USP5/USF1/ATG5 axis [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Therefore, ATG5 serves as a crucial intermediate link in CELF1-regulated autophagy and ADR resistance in AML.</p>
<p id="Par21">Subsequently, we performed RIP-qPCR and RNA pull-down experiments to confirm the direct interaction between CELF1 protein and ATG5 mRNA. Moreover, mRNA decay experiments demonstrated that knocking down CELF1 expression significantly reduced the half-life of ATG5 mRNA. Previous studies have shown that CELF1, also known as CUG-repeat binding protein 1 (CUGBP1), contains three RNA recognition motifs (RRMs) that specifically bind to CUG repeat sequences (such as CUGCUG) in the N-terminal RRM (RRM1 and RRM2), and UG repeat sequences (such as UGUGUG, CGUGUG) in the C-terminal RRM3, mediating alternative splicing events and mRNA stability [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>–<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>, <a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. Through sequence alignment, we found two UGUGUG sites in the CDS region and one CUGCUG site in the 3’UTR region of ATG5 mRNA. Binding activity experiments with different segments of CELF1 and ATG5 transcripts revealed significant differences in binding affinity between segments. Regions containing two UGUGUG sites showed the strongest binding capacity, while regions containing one CUGCUG site had weaker but synergistic binding capabilities. Therefore, CELF1 likely positively regulates ATG5 mRNA stability through specific binding to these repeat sequences, although the exact mechanism by which CELF1 promotes ATG5 mRNA stability remains to be elucidated.</p>
<p id="Par22">In conclusion, this study demonstrates that CELF1 is a novel AML chemotherapy resistance-related protein that directly targets and regulates ATG5 mRNA stability, promoting its expression and triggering protective autophagy-mediated drug resistance in cells. Our findings provide new insights into the potential mechanisms of AML chemotherapy resistance, which will help clarify the precise regulatory mechanisms of AML chemotherapy resistance and offer a new perspective on CELF1 and other RBPs as novel therapeutic targets for AML.</p></section><section id="Sec11"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec12"><h3 class="pmc_sec_title">Bioinformatics analysis</h3>
<p id="Par23">The pan-cancer analysis of the CELF1 gene was conducted using data from The Cancer Genome Atlas (TCGA) database. CELF1 expression and clinical data for AML were acquired from the TCGA database. Preprocessing steps were performed, including normalization and filtering of low-expressed genes. To examine the correlation between CELF1 expression and ATG5 and CDKN1A in TCGA, Spearman correlation analysis was performed on log-transformed and normalized RNA-Seq data. Autophagy genes from the Human Autophagy Database (<a href="http://www.autophagy.lu/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.autophagy.lu/</a>) were used for screening downstream target genes of CELF1. Analyzed data are available in Supplementary Table <a href="#MOESM1" class="usa-link">S1</a>.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Cell culture</h3>
<p id="Par24">The AML cell lines (HL-60, MOLM-13, U937, THP-1, and KG-1) and the human bone marrow stromal cell line (HS-5) were obtained from ATCC and cultured in appropriate growth media. The AML cells were maintained in RPMI-1640 medium supplemented with 10% FBS and 1% penicillin-streptomycin, while the HS-5 cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin. Media were changed regularly to sustain optimal cell growth. All cells were incubated at 37 °C with 5% CO<sub>2</sub> in a humidified atmosphere.</p>
<p id="Par25">ADR-resistant cell lines were established using a stepwise selection method. The parental cell lines (HL-60 and KG-1) were gradually exposed to increasing concentrations of ADR over several months. Starting with a low concentration, the cells were cultured and passaged in progressively higher ADR concentrations until an ADR-resistant cell line was obtained.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Transfection of cells</h3>
<p id="Par26">Cells were transfected with either siRNA targeting CELF1 to achieve knockdown or a ATG5 overexpression plasmid using Lipofectamine 2000. the specific siRNA and a negative control or overexpression plasmid and an empty vector control were diluted in serum-free growth medium and added to cells at 50–70% confluency. Following incubation, the cells were cultured at 37 °C for the appropriate duration to facilitate efficient siRNA and DNA uptake.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Cell viability assay</h3>
<p id="Par27">Cell viability was assessed using the Cell Counting Kit-8 (CCK-8) assay according to the manufacturer’s instructions. Briefly, cells in each group were seeded into 96-well plates at a density of 2 × 10<sup>3</sup> cells/well. After incubation for 48 h, the absorbance was determined by using a microplate reader set at a wavelength of 450 nm. The experiments were repeated in triplicate, independently.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Cell apoptosis assay</h3>
<p id="Par28">Cell apoptosis was assessed using the Annexin V-FITC/PI staining assay followed by flow cytometry analysis. Briefly, cells subjected to experimental treatments were collected, washed with PBS, and stained with Annexin V-FITC and PI according to the assay kit instructions. Flow cytometry analysis was then performed to determine the percentage of apoptotic cells based on Annexin V-FITC and PI fluorescence signals. Statistical analysis was conducted to compare the percentage of apoptotic cells between experimental and control groups, with a significance level set at <em>P</em> &lt; 0.05.</p></section><section id="Sec17"><h3 class="pmc_sec_title">RT-qPCR</h3>
<p id="Par29">TRIzol reagent was utilized to extract total RNA from cells. The concentration and purity of the extracted RNAs were assessed using a NanoDrop One Spectrophotometer. Subsequently, cDNA synthesis was carried out following the manufacturer’s instructions provided with the PrimeScript RT reagent Kit. Real-time quantitative PCR (RT-qPCR) was performed utilizing the TB Green Premix Ex Taq kit. The primers used were as follows: CELF1 F: ATGGCACAGACGGCTATCAAGG, CELF1 R: CACAGATGCTGCGCTGATTTGC; ATG5 F: GCAGATGGACAGTTGCACACAC, ATG5 R: GAGGTGTTTCCAACATTGGCTCA; β-actin F: TGGCACCCAGCACAATGAA, β-actin R: CTAAGTCATAGTCCGCCTAGAAGCA. Relative gene expression was normalized to β-actin based on the 2<sup>−ΔΔCt</sup> method.</p></section><section id="Sec18"><h3 class="pmc_sec_title">Western blot assays</h3>
<p id="Par30">Cells were lysed in RIPA buffer supplemented with protease and phosphatase inhibitors. The protein concentration was determined using a BCA protein assay kit. Equal amounts of protein samples were separated by SDS-PAGE and transferred onto PVDF membrane. After blocking non-specific binding, the membrane was probed overnight at 4 °C with primary antibodies(CELF1, CST #95084; Autophagy Antibody Sampler Kit, CST #4445; mTOR, CST #2983; p-mTOR, CST #5536; CDKN1A, CST #2947) specific to the target proteins. Following washing, the membrane was incubated with HRP-conjugated secondary antibodies, and protein bands were visualized using ECL detection reagents.</p></section><section id="Sec19"><h3 class="pmc_sec_title">Transmission electron microscopy</h3>
<p id="Par31">Autophagic structures were observed using electron microscopy. Cells were seeded onto culture dishes and treated accordingly. Following treatment, cells were fixed, dehydrated, and embedded in resin. Ultrathin sections were cut, stained, and mounted on copper grids. Autophagic structures, including autophagosomes and autolysosomes, were examined under a transmission electron microscope operated. Representative images were captured to visualize the observed structures associated with autophagy.</p></section><section id="Sec20"><h3 class="pmc_sec_title">Tandem mRFP-GFP-LC3 reporter assay</h3>
<p id="Par32">Cells were transfected with the mRFP-GFP-LC3 plasmid, followed by designated pharmacological treatments (BafA1, rapamycin) or genetic manipulations (siRNA-mediated CELF1 knockdown, ATG5 overexpression). After 24–48 h, cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and imaged using a confocal microscope. Yellow (GFP<sup>+</sup>/mRFP<sup>+</sup>) and red (GFP<sup>−</sup>/mRFP<sup>+</sup>) puncta representing autophagosomes and autolysosomes, were counted in cells per group using ImageJ, respectively. Autophagic flux was calculated as the ratio of red-to-yellow puncta across experimental conditions.</p></section><section id="Sec21"><h3 class="pmc_sec_title">RNA sequencing</h3>
<p id="Par33">Total RNA was isolated from CELF1 knockdown or control HL-60/ADR cells by using Trizol reagent. The quality and quantity of the RNA samples were assessed with a spectrophotometer. The high‐throughput sequencing and analyses for mRNA were carried out by Majorbio Technology (Shanghai, China). Analyzed data are available in Supplementary Table <a href="#MOESM1" class="usa-link">S1</a>.</p></section><section id="Sec22"><h3 class="pmc_sec_title">RIP-qPCR</h3>
<p id="Par34">Approximately 1 × 10<sup>7</sup> HL-60/ADR cells were harvested and rinsed with PBS. RNA immunoprecipitation (RIP) was conducted using the Magna RIP Kit (Millipore) following the manufacturer’s instructions. In brief, cells were lysed for 60 min on ice in RIP Lysis Buffer supplemented with protease inhibitor and RNase inhibitor. Then, 50 μL of magnetic beads were coupled with either anti-CELF1 antibodies or anti-rabbit IgG antibodies. The cell lysates were incubated with the bead pellet overnight at 4 °C. Immunoprecipitated RNA was extracted from the pellet using phenol chloroform, while the immunoprecipitate underwent proteinase K treatment and subsequent RT-qPCR analysis.</p></section><section id="Sec23"><h3 class="pmc_sec_title">RNA pull-down assay</h3>
<p id="Par35">ATG5 or antisense RNA was transcribed in vitro from the pcDNA3.1 vector using the TranscriptAid T7 High Yield Transcription Kit. The transcribed ATG5 was purified with the PureLink RNA Mini Kit and subsequently biotin-labeled using the Biotin 3’ End DNA Labeling Kit. Next, the biotinylated RNA was incubated with whole-cell lysate from HL-60/ADR cells at room temperature for 1 h. The RNA-protein complex was then isolated using streptavidin magnetic beads, and the bound proteins were further extracted for subsequent Western blot analysis.</p>
<p id="Par36">Three biotinylated RNA fragments spanning the ATG5 mRNA sequence were generated. Whole cell lysates from 293T cells overexpressing CELF1 were incubated with the biotinylated RNA fragments for 1 h at room temperature to allow for RNA-protein complex formation. Streptavidin magnetic beads were then used to isolate the RNA-protein complexes, and the bound proteins were extracted for subsequent Western blot analysis.</p></section><section id="Sec24"><h3 class="pmc_sec_title">RNA stability assay</h3>
<p id="Par37">To assess ATG5 mRNA stability, HL-60/ADR cells were treated with Actinomycin D, a transcriptional inhibitor. After seeding, Actinomycin D was added at 5 μM, while control cells received vehicle treatment. Cells were then incubated for various time intervals to allow for RNA degradation. Total RNA was extracted from harvested cells using a TRIzol and assessed for quality and quantity. Subsequently, cDNA synthesis was performed, and the expression levels of target RNAs were measured at each time point using quantitative real-time PCR or other appropriate techniques. Data were normalized to housekeeping genes and analyzed to determine the rate of RNA degradation under Actinomycin D treatment.</p></section><section id="Sec25"><h3 class="pmc_sec_title">CELF1-mediated drug resistance of AML cells in vivo</h3>
<p id="Par38">Immunocompromised NSG mice (5 weeks old) were purchased from Shanghai SLAC Laboratory Animal Co., Ltd. HL-60/ADR cells transfected with sh-CELF1 or OE-ATG5 resuspended in PBS were injected directly into via tail vein to mimic systemic dissemination. Tumor growth and progression were monitored by measuring leukemic burden in peripheral blood samples obtained at different time points. Fluorescence imaging was employed to visualize the localization and intensity of fluorescently labeled AML cells within live animals. All the mice were performed euthanasia after the experiment to ensure the welfare and ethical treatment of the animals involved.</p></section><section id="Sec26"><h3 class="pmc_sec_title">H&amp;E staining</h3>
<p id="Par39">Tissues (spleen, lung, liver, and kidney) were collected, fixed in 4% paraformaldehyde, and embedded in paraffin. Sections (4 µm) were deparaffinized, rehydrated, and stained with hematoxylin for 5 min, followed by differentiation in 1% acid-ethanol and bluing in tap water. Slides were counterstained with eosin for 2 min, dehydrated, cleared in xylene, and mounted with neutral resin. Images were captured using a light microscope to assess tissue infiltration and structural integrity across experimental groups.</p></section><section id="Sec27"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par40">All statistical analyses were performed using GraphPad Prism 10 software. Data were expressed as mean ± standard deviation (SD) or as indicated. A Student’s <em>t</em> test was used to analyze two group comparisons. Additionally, correlation analysis was conducted to evaluate the association between variables of interest. Differences were considered statistically significant at <em>P</em> &lt; 0.05.</p></section></section><section id="Sec28"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12334686/bin/41419_2025_7926_MOESM1_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Table S1</a><sup> (13.4MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12334686/bin/41419_2025_7926_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">41419_2025_7926_MOESM2_ESM.docx</a><sup> (10MB, docx) </sup><p>Supplementary Figures and Figure legends</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12334686/bin/41419_2025_7926_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Original data files of Western blot</a><sup> (4.6MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM4"><div class="media p"><div class="caption">
<a href="/articles/instance/12334686/bin/41419_2025_7926_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">41419_2025_7926_MOESM4_ESM.xlsx</a><sup> (17.5KB, xlsx) </sup><p>Original data files (qPCR original Ct values)</p>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors sincerely acknowledge the support from the Key Discipline of Zhejiang Province in Public Health and Preventive Medicine (First Class, Category A), Hangzhou Medical College.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>WC and XL conceived and designed the experiments; XL, JL and QQ performed the bioinformatic analyses and carried out the biological experiments; JL and LZ operated the cell and animal experiments; LW analyzed the data; XL and WC wrote the paper; DH and QX revised the manuscript. All authors read and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by grants from Natural Science Foundation of Zhejiang Province (LGF22H080016), Zhejiang Medical Health Science and Technology Project (No. 2022RC124), Key Research and Development Select Projects of Zhejiang Provincial Department of Science and Technology (2020C03008), Hangzhou Medical College Basal Research Fund (KYZD2024004), and Institute Special Fund (No. YS2022010).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The authors declare that all data supporting the findings of this study are available within the article.</p></section><section id="FPar1"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par41">The authors declare no competing interests.</p></section><section id="FPar2"><h2 class="pmc_sec_title">Ethics approval</h2>
<p id="Par42">This study was approved by the Medical Ethics Committee of Hangzhou Medical College(No.2021-106). All animal care procedures and experiments were performed according to the guidelines of the Institutional Animal Care and Use Committee (IACUC) guidelines.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p>Edited by Professor Mauro Piacentini</p></div>
<div class="fn p" id="fn2"><p><strong>Publisher’s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Dongsheng Huang, Email: dshuang@hmc.edu.cn.</p>
<p>Qiuran Xu, Email: xuqiuran@hmc.edu.cn.</p>
<p>Wenhu Chen, Email: chenwenhu@hmc.edu.cn.</p></section><section id="sec29"><h2 class="pmc_sec_title">Supplementary information</h2>
<p>The online version contains supplementary material available at 10.1038/s41419-025-07926-0.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Döhner H, Wei AH, Löwenberg B. Towards precision medicine for AML. Nat Rev Clin Oncol. 2021;18:577–90.
</cite> [<a href="https://doi.org/10.1038/s41571-021-00509-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34006997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?D%C3%B6hner%20H,%20Wei%20AH,%20L%C3%B6wenberg%20B.%20Towards%20precision%20medicine%20for%20AML.%20Nat%20Rev%20Clin%20Oncol.%202021;18:577%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 2003;3:89–101.
</cite> [<a href="https://doi.org/10.1038/nrc989" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12563308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tenen%20DG.%20Disruption%20of%20differentiation%20in%20human%20cancer:%20AML%20shows%20the%20way.%20Nat%20Rev%20Cancer.%202003;3:89%E2%80%93101." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Stein EM, Tallman MS. Emerging therapeutic drugs for AML. Blood. 2016;127:71–8.
</cite> [<a href="https://doi.org/10.1182/blood-2015-07-604538" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4915807/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26660428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stein%20EM,%20Tallman%20MS.%20Emerging%20therapeutic%20drugs%20for%20AML.%20Blood.%202016;127:71%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Liu H. Emerging agents and regimens for AML. J Hematol Oncol. 2021;14:49.
</cite> [<a href="https://doi.org/10.1186/s13045-021-01062-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7989091/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33757574/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20H.%20Emerging%20agents%20and%20regimens%20for%20AML.%20J%20Hematol%20Oncol.%202021;14:49." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Wang E, Lu SX, Pastore A, Chen X, Imig J, Lee SC-W, et al. Targeting an RNA-binding protein network in acute myeloid leukemia. Cancer Cell. 2019;35:369–84. e7.
</cite> [<a href="https://doi.org/10.1016/j.ccell.2019.01.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6424627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30799057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20E,%20Lu%20SX,%20Pastore%20A,%20Chen%20X,%20Imig%20J,%20Lee%20SC-W,%20et%20al.%20Targeting%20an%20RNA-binding%20protein%20network%20in%20acute%20myeloid%20leukemia.%20Cancer%20Cell.%202019;35:369%E2%80%9384.%20e7." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Prieto C, Nguyen DT, Liu Z, Wheat J, Perez A, Gourkanti S, et al. Transcriptional control of CBX5 by the RNA-binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia. Nat Cancer. 2021;2:741–57.
</cite> [<a href="https://doi.org/10.1038/s43018-021-00220-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8388313/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34458856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Prieto%20C,%20Nguyen%20DT,%20Liu%20Z,%20Wheat%20J,%20Perez%20A,%20Gourkanti%20S,%20et%20al.%20Transcriptional%20control%20of%20CBX5%20by%20the%20RNA-binding%20proteins%20RBMX%20and%20RBMXL1%20maintains%20chromatin%20state%20in%20myeloid%20leukemia.%20Nat%20Cancer.%202021;2:741%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Nasiri-Aghdam M, Garcia-Garduño TC, Jave-Suárez LF. Celf family proteins in cancer: Highlights on the rna-binding protein/noncoding rna regulatory axis. Int J Mol Sci. 2021;22:11056.
</cite> [<a href="https://doi.org/10.3390/ijms222011056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8537729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34681716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nasiri-Aghdam%20M,%20Garcia-Gardu%C3%B1o%20TC,%20Jave-Su%C3%A1rez%20LF.%20Celf%20family%20proteins%20in%20cancer:%20Highlights%20on%20the%20rna-binding%20protein/noncoding%20rna%20regulatory%20axis.%20Int%20J%20Mol%20Sci.%202021;22:11056." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, et al. Identification of a (CUG) n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 1996;24:4407–14.
</cite> [<a href="https://doi.org/10.1093/nar/24.22.4407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC146274/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8948631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Timchenko%20LT,%20Miller%20JW,%20Timchenko%20NA,%20DeVore%20DR,%20Datar%20KV,%20Lin%20L,%20et%20al.%20Identification%20of%20a%20(CUG)%20n%20triplet%20repeat%20RNA-binding%20protein%20and%20its%20expression%20in%20myotonic%20dystrophy.%20Nucleic%20Acids%20Res.%201996;24:4407%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Belanger K, Nutter CA, Li J, Tasnim S, Liu P, Yu P, et al. CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart. Biochem Biophys Res Commun. 2018;503:3205–11.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2018.08.126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6142808/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30158053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Belanger%20K,%20Nutter%20CA,%20Li%20J,%20Tasnim%20S,%20Liu%20P,%20Yu%20P,%20et%20al.%20CELF1%20contributes%20to%20aberrant%20alternative%20splicing%20patterns%20in%20the%20type%201%20diabetic%20heart.%20Biochem%20Biophys%20Res%20Commun.%202018;503:3205%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Wang H, Huang R, Guo W, Qin X, Yang Z, Yuan Z, et al. RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer. Clin Sci. 2020;134:1973–90.</cite> [<a href="https://doi.org/10.1042/CS20191174" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32677671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20H,%20Huang%20R,%20Guo%20W,%20Qin%20X,%20Yang%20Z,%20Yuan%20Z,%20et%20al.%20RNA-binding%20protein%20CELF1%20enhances%20cell%20migration,%20invasion,%20and%20chemoresistance%20by%20targeting%20ETS2%20in%20colorectal%20cancer.%20Clin%20Sci.%202020;134:1973%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Liu L, Ouyang M, Rao JN, Zou T, Xiao L, Chung HK, et al. Competition between RNA-binding proteins CELF1 and HuR modulates MYC translation and intestinal epithelium renewal. Mol Biol Cell. 2015;26:1797–810.
</cite> [<a href="https://doi.org/10.1091/mbc.E14-11-1500" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4436827/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25808495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20L,%20Ouyang%20M,%20Rao%20JN,%20Zou%20T,%20Xiao%20L,%20Chung%20HK,%20et%20al.%20Competition%20between%20RNA-binding%20proteins%20CELF1%20and%20HuR%20modulates%20MYC%20translation%20and%20intestinal%20epithelium%20renewal.%20Mol%20Biol%20Cell.%202015;26:1797%E2%80%93810." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Shaffer BC, Gillet J-P, Patel C, Baer MR, Bates SE, Gottesman MM. Drug resistance: still a daunting challenge to the successful treatment of AML. Drug Resist Updates. 2012;15:62–9.</cite> [<a href="https://doi.org/10.1016/j.drup.2012.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3348380/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22409994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shaffer%20BC,%20Gillet%20J-P,%20Patel%20C,%20Baer%20MR,%20Bates%20SE,%20Gottesman%20MM.%20Drug%20resistance:%20still%20a%20daunting%20challenge%20to%20the%20successful%20treatment%20of%20AML.%20Drug%20Resist%20Updates.%202012;15:62%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>McNeer NA, Philip J, Geiger H, Ries RE, Lavallee V-P, Walsh M, et al. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia. Leukemia. 2019;33:1934–43.
</cite> [<a href="https://doi.org/10.1038/s41375-019-0402-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6687545/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30760869/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McNeer%20NA,%20Philip%20J,%20Geiger%20H,%20Ries%20RE,%20Lavallee%20V-P,%20Walsh%20M,%20et%20al.%20Genetic%20mechanisms%20of%20primary%20chemotherapy%20resistance%20in%20pediatric%20acute%20myeloid%20leukemia.%20Leukemia.%202019;33:1934%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013;4:e838-e.
</cite> [<a href="https://doi.org/10.1038/cddis.2013.350" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3824660/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24113172/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sui%20X,%20Chen%20R,%20Wang%20Z,%20Huang%20Z,%20Kong%20N,%20Zhang%20M,%20et%20al.%20Autophagy%20and%20chemotherapy%20resistance:%20a%20promising%20therapeutic%20target%20for%20cancer%20treatment.%20Cell%20Death%20Dis.%202013;4:e838-e." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Hou X, Jiang J, Tian Z, Wei L. Autophagy and tumour chemotherapy. In: Weidong Le, editor. Autophagy: Biology and Diseases: Clinical Science. New York: Springer; 2020; 351–74.</cite> [<a href="https://doi.org/10.1007/978-981-15-4272-5_24" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32671759/" class="usa-link">PubMed</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Long W, Zhang L, Wang Y, Xie H, Wang L, Yu H. Research progress and prospects of autophagy in the mechanism of multidrug resistance in tumors. J Oncol. 2022;2022:7032614.
</cite> [<a href="https://doi.org/10.1155/2022/7032614" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8818414/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35136409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Long%20W,%20Zhang%20L,%20Wang%20Y,%20Xie%20H,%20Wang%20L,%20Yu%20H.%20Research%20progress%20and%20prospects%20of%20autophagy%20in%20the%20mechanism%20of%20multidrug%20resistance%20in%20tumors.%20J%20Oncol.%202022;2022:7032614." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Qin Y, Ashrafizadeh M, Mongiardini V, Grimaldi B, Crea F, Rietdorf K, et al. Autophagy and cancer drug resistance in dialogue: pre-clinical and clinical evidence. Cancer Lett. 2023;570:216307.</cite> [<a href="https://doi.org/10.1016/j.canlet.2023.216307" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37451426/" class="usa-link">PubMed</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Chang H, Zou Z. Targeting autophagy to overcome drug resistance: further developments. J Hematol Oncol. 2020;13:159.
</cite> [<a href="https://doi.org/10.1186/s13045-020-01000-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7687716/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33239065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chang%20H,%20Zou%20Z.%20Targeting%20autophagy%20to%20overcome%20drug%20resistance:%20further%20developments.%20J%20Hematol%20Oncol.%202020;13:159." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Piya S, Andreeff M, Borthakur G. Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia. Autophagy. 2017;13:214–5.
</cite> [<a href="https://doi.org/10.1080/15548627.2016.1245263" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5240828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27797294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Piya%20S,%20Andreeff%20M,%20Borthakur%20G.%20Targeting%20autophagy%20to%20overcome%20chemoresistance%20in%20acute%20myleogenous%20leukemia.%20Autophagy.%202017;13:214%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Du W, Xu A, Huang Y, Cao J, Zhu H, Yang B, et al. The role of autophagy in targeted therapy for acute myeloid leukemia. Autophagy. 2021;17:2665–79.
</cite> [<a href="https://doi.org/10.1080/15548627.2020.1822628" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8525957/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32917124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Du%20W,%20Xu%20A,%20Huang%20Y,%20Cao%20J,%20Zhu%20H,%20Yang%20B,%20et%20al.%20The%20role%20of%20autophagy%20in%20targeted%20therapy%20for%20acute%20myeloid%20leukemia.%20Autophagy.%202021;17:2665%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Wang H-l, Li J-n, Kan W-j, Xu G-y, Luo G-h, Song N, et al. Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathway. Acta Pharmacol Sin. 2023;44:2296–306.
</cite> [<a href="https://doi.org/10.1038/s41401-023-01112-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10618541/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37316630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20H-l,%20Li%20J-n,%20Kan%20W-j,%20Xu%20G-y,%20Luo%20G-h,%20Song%20N,%20et%20al.%20Chloroquine%20enhances%20the%20efficacy%20of%20chemotherapy%20drugs%20against%20acute%20myeloid%20leukemia%20by%20inactivating%20the%20autophagy%20pathway.%20Acta%20Pharmacol%20Sin.%202023;44:2296%E2%80%93306." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu Y, et al. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia. 2011;25:23–31.
</cite> [<a href="https://doi.org/10.1038/leu.2010.225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20927132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20L,%20Yang%20M,%20Kang%20R,%20Wang%20Z,%20Zhao%20Y,%20Yu%20Y,%20et%20al.%20HMGB1-induced%20autophagy%20promotes%20chemotherapy%20resistance%20in%20leukemia%20cells.%20Leukemia.%202011;25:23%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Chen X, Chen X, Huang Y, Lin J, Wu Y, Chen Y. TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT/mTOR signaling. Cell Death Dis. 2021;12:1058.
</cite> [<a href="https://doi.org/10.1038/s41419-021-04336-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8575913/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34750375/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20X,%20Chen%20X,%20Huang%20Y,%20Lin%20J,%20Wu%20Y,%20Chen%20Y.%20TCP1%20increases%20drug%20resistance%20in%20acute%20myeloid%20leukemia%20by%20suppressing%20autophagy%20via%20activating%20AKT/mTOR%20signaling.%20Cell%20Death%20Dis.%202021;12:1058." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Hu X, Mei S, Meng W, Xue S, Jiang L, Yang Y, et al. CXCR4-mediated signaling regulates autophagy and influences acute myeloid leukemia cell survival and drug resistance. Cancer Lett. 2018;425:1–12.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2018.03.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29574276/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20X,%20Mei%20S,%20Meng%20W,%20Xue%20S,%20Jiang%20L,%20Yang%20Y,%20et%20al.%20CXCR4-mediated%20signaling%20regulates%20autophagy%20and%20influences%20acute%20myeloid%20leukemia%20cell%20survival%20and%20drug%20resistance.%20Cancer%20Lett.%202018;425:1%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Dasgupta T, Ladd AN. The importance of CELF control: molecular and biological roles of the CUG‐BP, Elav‐like family of RNA‐binding proteins. Wiley Interdiscip Rev RNA. 2012;3:104–21.
</cite> [<a href="https://doi.org/10.1002/wrna.107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3243963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22180311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dasgupta%20T,%20Ladd%20AN.%20The%20importance%20of%20CELF%20control:%20molecular%20and%20biological%20roles%20of%20the%20CUG%E2%80%90BP,%20Elav%E2%80%90like%20family%20of%20RNA%E2%80%90binding%20proteins.%20Wiley%20Interdiscip%20Rev%20RNA.%202012;3:104%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Edwards J, Malaurie E, Kondrashov A, Long J, de Moor CH, Searle MS, et al. Sequence determinants for the tandem recognition of UGU and CUG rich RNA elements by the two N—terminal RRMs of CELF1. Nucleic Acids Res. 2011;39:8638–50.
</cite> [<a href="https://doi.org/10.1093/nar/gkr510" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3201864/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21743084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Edwards%20J,%20Malaurie%20E,%20Kondrashov%20A,%20Long%20J,%20de%20Moor%20CH,%20Searle%20MS,%20et%20al.%20Sequence%20determinants%20for%20the%20tandem%20recognition%20of%20UGU%20and%20CUG%20rich%20RNA%20elements%20by%20the%20two%20N%E2%80%94terminal%20RRMs%20of%20CELF1.%20Nucleic%20Acids%20Res.%202011;39:8638%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Qin WJ, Shi J-J, Chen R-Y, Li C-Y, Liu Y-J, Lu J-F, et al. Curriculum vitae of CUG binding protein 1 (CELF1) in homeostasis and diseases: a systematic review. Cell Mol Biol Lett. 2024;29:32.
</cite> [<a href="https://doi.org/10.1186/s11658-024-00556-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10916161/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38443798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qin%20WJ,%20Shi%20J-J,%20Chen%20R-Y,%20Li%20C-Y,%20Liu%20Y-J,%20Lu%20J-F,%20et%20al.%20Curriculum%20vitae%20of%20CUG%20binding%20protein%201%20(CELF1)%20in%20homeostasis%20and%20diseases:%20a%20systematic%20review.%20Cell%20Mol%20Biol%20Lett.%202024;29:32." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Barley K, Navada SC. Acute myeloid leukemia. In: William K. Oh, Ajai Chari editors. Mount Sinai Expert Guides: Oncology. Hoboken, NJ: Wiley‑Blackwell; 2019; 308–18.</cite>
</li>
<li id="CR29">
<span class="label">29.</span><cite>Degos L. Differentiating agents in the treatment of leukemia. Leuk Res. 1990;14:717–9.
</cite> [<a href="https://doi.org/10.1016/0145-2126(90)90101-e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2201823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Degos%20L.%20Differentiating%20agents%20in%20the%20treatment%20of%20leukemia.%20Leuk%20Res.%201990;14:717%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Kuendgen A, Germing U. Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly. Cancer Treat Rev. 2009;35:97–120.
</cite> [<a href="https://doi.org/10.1016/j.ctrv.2008.09.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18951721/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kuendgen%20A,%20Germing%20U.%20Emerging%20treatment%20strategies%20for%20acute%20myeloid%20leukemia%20(AML)%20in%20the%20elderly.%20Cancer%20Treat%20Rev.%202009;35:97%E2%80%93120." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Vembuli H, Gor R, Ramalingam S, Perales S, Rajasingh J. RNA binding proteins in cancer chemotherapeutic drug resistance. Front Cell Dev Biol. 2024;12:1308102.
</cite> [<a href="https://doi.org/10.3389/fcell.2024.1308102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10847363/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38328550/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vembuli%20H,%20Gor%20R,%20Ramalingam%20S,%20Perales%20S,%20Rajasingh%20J.%20RNA%20binding%20proteins%20in%20cancer%20chemotherapeutic%20drug%20resistance.%20Front%20Cell%20Dev%20Biol.%202024;12:1308102." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Feng Y, Zhu S, Liu T, Zhi G, Shao B, Liu J, et al. Surmounting cancer drug resistance: new perspective on RNA-binding proteins. Pharmaceuticals. 2023;16:1114.
</cite> [<a href="https://doi.org/10.3390/ph16081114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10458901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37631029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feng%20Y,%20Zhu%20S,%20Liu%20T,%20Zhi%20G,%20Shao%20B,%20Liu%20J,%20et%20al.%20Surmounting%20cancer%20drug%20resistance:%20new%20perspective%20on%20RNA-binding%20proteins.%20Pharmaceuticals.%202023;16:1114." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Mehta M, Raguraman R, Ramesh R, Munshi A. RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer. Adv Drug Deliv Rev. 2022;191:114569.
</cite> [<a href="https://doi.org/10.1016/j.addr.2022.114569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10411638/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36252617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mehta%20M,%20Raguraman%20R,%20Ramesh%20R,%20Munshi%20A.%20RNA%20binding%20proteins%20(RBPs)%20and%20their%20role%20in%20DNA%20damage%20and%20radiation%20response%20in%20cancer.%20Adv%20Drug%20Deliv%20Rev.%202022;191:114569." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Zhao Y, Mir C, Garcia-Mayea Y, Paciucci R, Kondoh H, LLeonart M, editors. RNA-binding proteins: underestimated contributors in tumorigenesis. Semin Cancer Biol. 2022;86:431–44.</cite> [<a href="https://doi.org/10.1016/j.semcancer.2022.01.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35124196/" class="usa-link">PubMed</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Jones K, Timchenko L, Timchenko NA. The role of CUGBP1 in age-dependent changes of liver functions. Ageing Res Rev. 2012;11:442–9.
</cite> [<a href="https://doi.org/10.1016/j.arr.2012.02.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3610417/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22446383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jones%20K,%20Timchenko%20L,%20Timchenko%20NA.%20The%20role%20of%20CUGBP1%20in%20age-dependent%20changes%20of%20liver%20functions.%20Ageing%20Res%20Rev.%202012;11:442%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Peng X, Shen X, Chen X, Liang R, Azares AR, Liu Y. Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity. Biochim Biophys Acta. 2015;1852:1490–7.
</cite> [<a href="https://doi.org/10.1016/j.bbadis.2015.04.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25887157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peng%20X,%20Shen%20X,%20Chen%20X,%20Liang%20R,%20Azares%20AR,%20Liu%20Y.%20Celf1%20regulates%20cell%20cycle%20and%20is%20partially%20responsible%20for%20defective%20myoblast%20differentiation%20in%20myotonic%20dystrophy%20RNA%20toxicity.%20Biochim%20Biophys%20Acta.%202015;1852:1490%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Wang X, Wang H, Ji F, Zhao S, Fang X. Lentivirus-mediated knockdown of CUGBP1 suppresses gastric cancer cell proliferation in vitro. Appl Biochem Biotechnol. 2014;173:1529–36.
</cite> [<a href="https://doi.org/10.1007/s12010-014-0937-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24818870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20X,%20Wang%20H,%20Ji%20F,%20Zhao%20S,%20Fang%20X.%20Lentivirus-mediated%20knockdown%20of%20CUGBP1%20suppresses%20gastric%20cancer%20cell%20proliferation%20in%20vitro.%20Appl%20Biochem%20Biotechnol.%202014;173:1529%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Wu LN, Xue YJ, Zhang LJ, Ma XM, Chen JF. Si-RNA mediated knockdown of CELF1 gene suppressed the proliferation of human lung cancer cells. Cancer Cell Int. 2013;13:115.
</cite> [<a href="https://doi.org/10.1186/1475-2867-13-115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3842801/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24237593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20LN,%20Xue%20YJ,%20Zhang%20LJ,%20Ma%20XM,%20Chen%20JF.%20Si-RNA%20mediated%20knockdown%20of%20CELF1%20gene%20suppressed%20the%20proliferation%20of%20human%20lung%20cancer%20cells.%20Cancer%20Cell%20Int.%202013;13:115." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Xia L, Sun C, Li Q, Feng F, Qiao E, Jiang L, et al. CELF1 is up-regulated in glioma and promotes glioma cell proliferation by suppression of CDKN1B. Int J Biol Sci. 2015;11:1314–24.
</cite> [<a href="https://doi.org/10.7150/ijbs.11344" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4625542/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26535026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xia%20L,%20Sun%20C,%20Li%20Q,%20Feng%20F,%20Qiao%20E,%20Jiang%20L,%20et%20al.%20CELF1%20is%20up-regulated%20in%20glioma%20and%20promotes%20glioma%20cell%20proliferation%20by%20suppression%20of%20CDKN1B.%20Int%20J%20Biol%20Sci.%202015;11:1314%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560–75.
</cite> [<a href="https://doi.org/10.1038/s41580-023-00585-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9980873/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36864290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Debnath%20J,%20Gammoh%20N,%20Ryan%20KM.%20Autophagy%20and%20autophagy-related%20pathways%20in%20cancer.%20Nat%20Rev%20Mol%20Cell%20Biol.%202023;24:560%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728–41.
</cite> [<a href="https://doi.org/10.1016/j.cell.2011.10.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22078875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mizushima%20N,%20Komatsu%20M.%20Autophagy:%20renovation%20of%20cells%20and%20tissues.%20Cell.%202011;147:728%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: regulator of cell death. Cell Death Dis. 2023;14:648.
</cite> [<a href="https://doi.org/10.1038/s41419-023-06154-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10551038/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37794028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20S,%20Yao%20S,%20Yang%20H,%20Liu%20S,%20Wang%20Y.%20Autophagy:%20regulator%20of%20cell%20death.%20Cell%20Death%20Dis.%202023;14:648." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, et al. Autophagy in major human diseases. EMBO J. 2021;40:e108863.
</cite> [<a href="https://doi.org/10.15252/embj.2021108863" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8488577/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34459017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Klionsky%20DJ,%20Petroni%20G,%20Amaravadi%20RK,%20Baehrecke%20EH,%20Ballabio%20A,%20Boya%20P,%20et%20al.%20Autophagy%20in%20major%20human%20diseases.%20EMBO%20J.%202021;40:e108863." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Zhang LH, Yang AJ, Wang M, Liu W, Wang CY, Xie XF, et al. Enhanced autophagy reveals vulnerability of P-gp mediated epirubicin resistance in triple negative breast cancer cells. Apoptosis. 2016;21:473–88.
</cite> [<a href="https://doi.org/10.1007/s10495-016-1214-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4915730/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26767845/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20LH,%20Yang%20AJ,%20Wang%20M,%20Liu%20W,%20Wang%20CY,%20Xie%20XF,%20et%20al.%20Enhanced%20autophagy%20reveals%20vulnerability%20of%20P-gp%20mediated%20epirubicin%20resistance%20in%20triple%20negative%20breast%20cancer%20cells.%20Apoptosis.%202016;21:473%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Lim SC, Hahm KS, Lee SH, Oh SH. Autophagy involvement in cadmium resistance through induction of multidrug resistance-associated protein and counterbalance of endoplasmic reticulum stress WI38 lung epithelial fibroblast cells. Toxicology. 2010;276:18–26.
</cite> [<a href="https://doi.org/10.1016/j.tox.2010.06.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20600546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lim%20SC,%20Hahm%20KS,%20Lee%20SH,%20Oh%20SH.%20Autophagy%20involvement%20in%20cadmium%20resistance%20through%20induction%20of%20multidrug%20resistance-associated%20protein%20and%20counterbalance%20of%20endoplasmic%20reticulum%20stress%20WI38%20lung%20epithelial%20fibroblast%20cells.%20Toxicology.%202010;276:18%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Xu T, Jiang L, Wang Z. The progression of HMGB1-induced autophagy in cancer biology. Onco Targets Ther. 2019;12:365–77.
</cite> [<a href="https://doi.org/10.2147/OTT.S185876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6317470/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30643434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20T,%20Jiang%20L,%20Wang%20Z.%20The%20progression%20of%20HMGB1-induced%20autophagy%20in%20cancer%20biology.%20Onco%20Targets%20Ther.%202019;12:365%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Evangelisti C, Evangelisti C, Chiarini F, Lonetti A, Buontempo F, Neri LM, et al. Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. Biochim Biophys Acta. 2015;1853:14–26.
</cite> [<a href="https://doi.org/10.1016/j.bbamcr.2014.09.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25284725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Evangelisti%20C,%20Evangelisti%20C,%20Chiarini%20F,%20Lonetti%20A,%20Buontempo%20F,%20Neri%20LM,%20et%20al.%20Autophagy%20in%20acute%20leukemias:%20a%20double-edged%20sword%20with%20important%20therapeutic%20implications.%20Biochim%20Biophys%20Acta.%202015;1853:14%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Changotra H, Kaur S, Yadav SS, Gupta GL, Parkash J, Duseja A. ATG5: a central autophagy regulator implicated in various human diseases. Cell Biochem Funct. 2022;40:650–67.
</cite> [<a href="https://doi.org/10.1002/cbf.3740" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36062813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Changotra%20H,%20Kaur%20S,%20Yadav%20SS,%20Gupta%20GL,%20Parkash%20J,%20Duseja%20A.%20ATG5:%20a%20central%20autophagy%20regulator%20implicated%20in%20various%20human%20diseases.%20Cell%20Biochem%20Funct.%202022;40:650%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Gao Z, Li C, Sun H, Bian Y, Cui Z, Wang N, et al. N(6)-methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors. Cell Death Differ. 2023;30:544–59.
</cite> [<a href="https://doi.org/10.1038/s41418-022-01107-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9950061/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36528756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20Z,%20Li%20C,%20Sun%20H,%20Bian%20Y,%20Cui%20Z,%20Wang%20N,%20et%20al.%20N(6)-methyladenosine-modified%20USP13%20induces%20pro-survival%20autophagy%20and%20imatinib%20resistance%20via%20regulating%20the%20stabilization%20of%20autophagy-related%20protein%205%20in%20gastrointestinal%20stromal%20tumors.%20Cell%20Death%20Differ.%202023;30:544%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Wang ZC, Huang FZ, Xu HB, Sun JC, Wang CF. MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5. Int J Biochem Cell Biol. 2019;111:63–71.
</cite> [<a href="https://doi.org/10.1016/j.biocel.2019.01.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30710750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20ZC,%20Huang%20FZ,%20Xu%20HB,%20Sun%20JC,%20Wang%20CF.%20MicroRNA-137%20inhibits%20autophagy%20and%20chemosensitizes%20pancreatic%20cancer%20cells%20by%20targeting%20ATG5.%20Int%20J%20Biochem%20Cell%20Biol.%202019;111:63%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Yu Z, Tang H, Chen S, Xie Y, Shi L, Xia S, et al. Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy. Drug Resist Updat. 2023;67:100915.
</cite> [<a href="https://doi.org/10.1016/j.drup.2022.100915" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36641841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20Z,%20Tang%20H,%20Chen%20S,%20Xie%20Y,%20Shi%20L,%20Xia%20S,%20et%20al.%20Exosomal%20LOC85009%20inhibits%20docetaxel%20resistance%20in%20lung%20adenocarcinoma%20through%20regulating%20ATG5-induced%20autophagy.%20Drug%20Resist%20Updat.%202023;67:100915." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Tsuda K, Kuwasako K, Takahashi M, Someya T, Inoue M, Terada T, et al. Structural basis for the sequence-specific RNA-recognition mechanism of human CUG-BP1 RRM3. Nucleic Acids Res. 2009;37:5151–66.
</cite> [<a href="https://doi.org/10.1093/nar/gkp546" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2731918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19553194/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsuda%20K,%20Kuwasako%20K,%20Takahashi%20M,%20Someya%20T,%20Inoue%20M,%20Terada%20T,%20et%20al.%20Structural%20basis%20for%20the%20sequence-specific%20RNA-recognition%20mechanism%20of%20human%20CUG-BP1%20RRM3.%20Nucleic%20Acids%20Res.%202009;37:5151%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12334686/bin/41419_2025_7926_MOESM1_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Table S1</a><sup> (13.4MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12334686/bin/41419_2025_7926_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">41419_2025_7926_MOESM2_ESM.docx</a><sup> (10MB, docx) </sup><p>Supplementary Figures and Figure legends</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12334686/bin/41419_2025_7926_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Original data files of Western blot</a><sup> (4.6MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12334686/bin/41419_2025_7926_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">41419_2025_7926_MOESM4_ESM.xlsx</a><sup> (17.5KB, xlsx) </sup><p>Original data files (qPCR original Ct values)</p>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The authors declare that all data supporting the findings of this study are available within the article.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cell Death &amp; Disease are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41419-025-07926-0"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41419_2025_Article_7926.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (4.3 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12334686/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12334686/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334686%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334686/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12334686/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12334686/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40781108/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12334686/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40781108/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12334686/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12334686/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="PBbkvPYFBEER0yKlLOpaK3JwEDq5kjBUwXY3vcEpk1xRzNqCmvsVzgW2jtXYsrhk">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
